未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Antidiarrheal prophylaxis with loperamide for patients with lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive breast cancer who received adjuvant pyrotinib plus nab-paclitaxel: a randomized sub-study of PHAEDRA
Wang, Changjun; Lin, Yan; Zhou, Yidong; Mao, Feng; Guan, Jinghong; Shen, Songjie; Wang, Xuejing; Zhang, Xiaohui; Zhang, Yanna; Pan, Bo; Zhong, Ying; Peng, Li; Li, Yan; Huang, Xin; Xu, Ying; Sun, Qiang
分享
收藏LncRNA-AP006284.1 promotes prostate cancer cell growth and motility by forming RNA-DNA triplexes and recruiting GNL3/SFPQ complex to facilitate RASSF7 transcription
Lu, Yali; Lin, Yan; Zhang, Xiaoyang; Yan, Jun; Kong, Zhe; Zhang, Lu; Wang, Chenji; Huang, Yan; Zhao, Shimin; Li, Yao
分享
收藏
分享
收藏
分享
收藏
分享
收藏Phase II study of pyrotinib plus nanoparticle albumin-bound (nab)-paclitaxel as adjuvant therapy for lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive early breast cancer (PHAEDRA)
Wang, Changjun; Zhou, Yidong; Lin, Yan; Mao, Feng; Guan, Jinghong; Zhang, Xiaohui; Shen, Songjie; Wang, Xuejing; Zhang, Yanna; Pan, Bo; Zhong, Ying; Peng, Li; Cao, Xi; Yao, Ru; Zhou, Xingtong; Xu, Chi; Xu, Ying; Sun, Qiang
分享
收藏
分享
收藏